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Abstract
Background: Pax7 encodes a transcription factor well-established as an important determinant of
mesencephalic identity and superior collicular development. Pax7 mutant mice, however, present
with no obvious morphological impairments to the superior colliculus. This finding is paradoxical
and has been attributed to functional redundancy afforded by its paralogue Pax3. Here we utilise
Pax7 mutant mice to investigate the precise role of this important developmental regulator during
superior collicular development and neuronal specification/differentiation. We also assess its
spatiotemporal relationship with Pax3 during embryonic development.
Results: Analysis of the superior colliculus of Pax7 mutant and wildtype mice at a variety of
developmental timepoints revealed that whilst correct initial specification is maintained, a
subpopulation of dorsal mesencephalic neurons is lost at early postnatal stages. Moreover, a
comparative analysis of embryonic Pax3 and Pax7 expression profiles indicate that Pax3 expression
overlaps extensively with that of Pax7 initially, but their expression domains increasingly diverge as
development progresses, coinciding spatiotemporally with neuronal differentiation and maturation
of the tissue. Furthermore, Pax3 expression is perturbed within the CNS of embryonic Pax7 mutant
mice.
Conclusion: In summary, these results demonstrate that during superior collicular development,
Pax7 is required to maintain a subpopulation of dorsal, mesencephalic neurons and partially
regulates, spatiotemporally, Pax3 expression within the CNS. The differential nature of Pax7 and
Pax3 with respect to neuronal differentiation may have implications for future stem cell therapies
aimed at exploiting their developmental capabilities.
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Background
It is evident that Pax7 is a multiplex contributor to correct
CNS development. This is exemplified by dynamic spati-
otemporal expression patterns, occurring from early
development and persisting in restricted regions through-
out adulthood. Pax7 expression initially occurs in the neu-
ral tube and mesencephalon from very early stages [1,2]
and is required for polarisation of the dorsoventral axis of
the neural tube [3] and specification of the superior collic-
ulus/tectum from the mesencephalic alar plate [4-7]. In
the developing superior colliculus, graded expression of
Pax7 establishes rostrocaudal and dorsoventral polarity.
Expression of Pax7 localises within superior collicular
neurons as development proceeds. This expression is
upregulated during retinal innervation and axonal arbori-
sation but reduced in Pax6 (Sey) mutant mice [7], with
reduced (20–30%) retinal innervation [8], confirming
that Pax7-expressing cells are responsive to retinal input.
Demonstrated colocalisation in superior collicular neu-
rons with the mapping marker ephrin-A2 validates Pax7
participation in retinotopic mapping [7]. Continued,
graded expression into adulthood is thought to maintain
a small population of dorsal neurons in the mature collic-
ulus [7,9], although the functional requirement for this
feature remains obscure.
Given the aforementioned importance of Pax7 in mesen-
cephalic and superior collicular development, the lack of
gross defects in this region in Pax7 mutant mice is surpris-
ing, and points to rescue by the paralogous Pax3 gene
which has overlapping expression domains [9,10]. Here,
within the superior colliculus, we seek to determine the
developmental role of Pax7 in specification of neurons,
and assess its spatiotemporal relationship with Pax3. We
have analysed Pax7 mutant mice [10] relative to wildtype
at key stages of development and results indicate that a
subpopulation of neurons is lost during early postnatal
stages. We show that this apparent loss of neurons is not
due to aberrant specification or proliferation, or cell-fate
switching/transdifferentiation to the astrocytic lineage,
but rather appears due to the inability of Pax7 mutant
mice to maintain a subpopulation of dorsal superior col-
licular neurons.
Furthermore, analysis of Pax3 expression in embryonic
wildtype and Pax7 mutant mice indicates crossregulation
between paralogues, and illustrates a functional diver-
gence during superior collicular development. We pro-
pose that within the superior colliculus initial overlapping
Pax3 expression ensures correct neuronal specification,
and temporospatial separation of expression patterns
leads to solitary expression of Pax7 during a critical period
of neuronal maturation, which abrogates the ability of
Pax3 to compensate, revealing the aberrant phenotype.
Results
Pax gene expression patterns
The Pax7 antibody has previously been demonstrated to
be suitable for use in mouse tissue by Western Blot analy-
sis [11]. The Pax3 antibody has been tested in vitro and in
vivo for specificity in recognition of mouse Pax3 by West-
ern Blot analysis [12].
Pax7 expression in wildtype mice
Within the anlage of the tectum, at the earliest embryonic
stage examined (E12.5), Pax7 expression occurs from the
mesencephalic ventricular zone to the most superficial
layer. Immunoreactive cells are most dense in the ven-
tricular and subventricular zones, then decrease in the
intermediate zone, which is larger rostrally compared to
the caudal region at this stage (Fig 1a–b). Pax7 expression
can also be detected within the subthalamus, pretectum,
pons, and in the ventricular zones of the cerebellar pri-
mordium, pons and myelencephalon (4th ventricle). This
profile concurs with in situ hybridisation results reported
previously at E13 [9], with the exception of expression
detected at the 4th ventricle. At E15.5, a large number of
immunoreactive cells are detected (Fig 2a) in the pre-
sumptive superior colliculus whilst expression declines in
the caudal tectum, reflecting the emerging distinction of
the tectum into the inferior and superior colliculi. Pax7+
cells also recede from the mesencephalic ventricular zone,
although remnants of expression can still be detected at
the dorsal ventricular surface, with cells also noted at the
ventral ventricular surface at certain mediolateral posi-
tions. Pax7+ cells can be detected up to the pial surface of
the superior colliculus with the exception of the stratum
zonale, which is now becoming evident (Fig 1c). Expres-
sion remains robust within the pons. Pax7 expression at
E18.5 is similar to that noted at E15.5 (Fig 1e), however
immunoreactivity is no longer detected within the ven-
tricular zone and expression within the subthalamus is
waning. At P5, while a rostrallow to caudalhigh, ventrallow to
dorsalhigh gradient is maintained, Pax7+ cell numbers are
reduced throughout the superior colliculus (Table 1; Fig
1g; Fig 2a,b,d,e; [7]). Cellular protein levels are similarly
graded (Fig 2f–g; [7]). Expression is also reduced at the
midbrain/hindbrain boundary, pons and subthalamus.
Even fewer Pax7+ cells are detected throughout the young
adult superior colliculus (P18.5) (Fig 1i; Fig 2a). Expres-
sion persists at the midbrain/hindbrain boundary and
rostral to the choroid plexus (4th ventricle), with weak
expression in the subthalamus (n = 3–5 at all stages).
Pax7 expression in Pax7+/- mutant mice
In Pax7+/- embryos, the Pax7 expression profile is grossly
indistinguishable from that of wildtype mice (Fig 1d,f);
cell counts, wt = 2248.67 ± 94.75; Pax7+/- = 2373.67 ±
206.88 (p > 0.05; n = 3; Fig 2a). However, at P5, there is a
dramatic reduction in the number of Pax7+ cells in the
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most superficial region of Pax7+/- mice relative to those of
wildtype mice (Table 1; Fig 1h; Fig 2b–e; n = 4 each). This
manifests as a distinct area near the pial surface that is
almost devoid of Pax7+ cells uniformly across the entire
rostrocaudal (Fig 2d) and mediolateral (data not shown)
axes. Moreover, the number of Pax7+ cells is reduced
throughout the dorsal half of the superior colliculus.
Although the reduction in the total number of Pax7+ cells
in Pax7+/- relative to wildtype mice at P5 does not reach
statistical significance, this phenomenon results in the
loss of graded cellular distribution across the dorsoventral
axis (Table 1; Fig 2e; p > 0.05). Concomitantly there is
some variation in cellular protein levels ventrally creating
a lack of graded expression medially (Fig 2g). Interest-
ingly, at P18.5 we did not discern any differences in Pax7
expression between heterozygous and wildtype mice; cell
numbers, wt = 828.5 ± 108.97; Pax7+/- = 913.60 ± 69.77 (p
> 0.05, Table 1; Fig 1i–j; Fig 2a; n = 3–5 at all stages).
Pax3 expression in wildtype and Pax7 mutant mice
At E12.5, in wildtype and Pax7 mutant mice Pax3 expres-
sion can be detected from the pretectum to the tectum in
the ventricular and subventricular zones, with rostral
expression lower in intensity relative to the mid-caudal
region (Fig 3a–b). Immunoreactivity is also evident in the
ventricular zones of the cerebellar primordium, pons and
myelencephalon, and at the midbrain/hindbrain bound-
ary. By E15.5 Pax3 expression within the superior collicu-
lus of wildtype mice is primarily restricted to the dorsal
ventricular zone, and the pons (Figs 3c,e). In Pax7+/-
mutant mice at this stage, Pax3+ expression expands ven-
trally within the myelencephalon and pons (Figs 3d,f). In
striking contrast to wildtype (Fig 3g) and Pax7+/- mice,
Pax7-/- mice demonstrate large numbers of Pax3+ cells
above the rostral ventricular zone (3rd ventricle) (Fig 3h).
Furthermore, Pax3+ cells can be detected at the ventral
ventricular surface in Pax7 mutant mice but not in
wildtype mice (Figs 3i–j). At E18.5, in wildtype (Fig 3k)
and heterozygous mice the pretectum and ventricular
zone of the superior colliculus remain Pax3+, although
only a remnant of expression within a small number of
weakly stained cells remains within the superior colliculus
and in the pons. By contrast, Pax3 immunoreactivity can-
not be detected within the ventricular zone of Pax7-/- mice
(Fig 3l) (n = 2–4 at all embryonic stages). Pax3 expression
could not be detected at P5 in wildtype or mutant mice
(data not shown).
Spatiotemporal assessment of neuronal proliferation and 
differentiation within the superior colliculus
To assess whether the loss of Pax7+ cells in the dorsal supe-
rior collicular region of Pax7 mutant mice was due to
altered proliferation we explored Ki67 expression at
E12.5. We could not detect any variation in expression
patterns between wildtype and mutant mice (data not
shown), indicating that cellular proliferation proceeds
normally, thus excluding neuronal precocity at this stage
(n = 3–4).
We next sought to relate observed differences in the Pax7
and Pax3 expression profiles to temporal differences in
neuronal differentiation. We have shown previously that
Pax7 co-localises with βIII-tubulin and ephrin-A2 in the
mouse superior colliculus at P5 [7]. We therefore used
these and other markers of early neuronal differentiation,
α-internexin and doublecortin as well as the mature neu-
ronal marker, NeuN to analyse neuronal differentiation in
wildtype and mutant mice.
The efficacy of βIII-tubulin to discriminate differentiating
neurons and tract formation in the mouse embryo has
been demonstrated previously [13]. At E12.5 we observed
βIII-tubulin+ cells predominantly located within the inter-
mediate zone at the pial surface of the tectum, identifying
the emerging stratum profundum (SP) (Fig 4a) containing
the first differentiating neurons of the superior colliculus
[14]. Immunolabelled cells were also observed further
ventrally at the rostral tectum, but were reduced in
number throughout the mid-caudal region, indicating a
rostral to caudal cellular maturation, with the occasional
immunoreactive cell seen in more ventral regions.
At E15.5 the SP is clearly visible in the ventral tectum, and
immunolabelled, horizontally-oriented processes are
now visible extending throughout the dorsorostral supe-
rior colliculus (see Additional file 1). These processes
extend more caudally at E18.5 and most likely represent
the incoming axons of retinal ganglion cells, the major
Table 1: Pax7+ cell distribution in the superior colliculus of wildtype and Pax7 mutant mice at P5.
Pax7+ Cell Distribution
D-V Axis aVentral aMid aDorsal #V-M #M-D #V-D
P5 +/+ 117.50 ± 8.29 311.50 ± 60.88 551.25 ± 106.79 .051 .025 .025
+/- 126.25 ± 34.97 257.75 ± 56.98 317.25 ± 85.55 .025 >0.05 >0.05
+/+; wildtype +/-; Pax7+/-
a values are Mean Cell Numbers ± SEM (n = 4).
# indicates a significant p value from paired t-test assessing variation between axis points, within wildtype and Pax7+/- mice.
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Pax7 expression profiles in the developing superior colliculus of Pax7 mutant and wildtype miceFigure 1
Pax7 expression profiles in the developing superior colliculus of Pax7 mutant and wildtype mice. Comparative 
Pax7 expression profiles throughout development of the mouse tectum/superior colliculus in wildtype (a,b,c,e,g,i) and Pax7+/- 
mice (d,f,h,j). Note expression within the intermediate zone (IZ) in both the rostral (a) and caudal (b) regions of wildtype mice 
at E12.5. The embryonic Pax7 profile is comparable between wildtype and Pax7+/- mice at E15.5 (c-d) and E18.5 (e-f), however 
at P5 there is a paucity of Pax7+ cells in the dorsalmost region of Pax7+/- mice relative to wildtype (g-h). At P18.5 Pax7 expres-
sion is similar between wildtype and Pax7+/- mice (i-j). Abbrev. IZ, intermediate zone; VZ/SVZ, ventricular zone/subventricular 
zone. Scale bar: a-b 100 μm, c-j 200 μm.
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Quantification of Pax7 expression in the superior colliculus of wildtype and Pax7+/- miceFigure 2
Quantification of Pax7 expression in the superior colliculus of wildtype and Pax7+/- mice. (a) Pax7+ cells in the supe-
rior colliculus of wildtype and Pax7 mutant mice at E15.5, P5 and P18.5 (n = 3–5). (b-c) Map of Pax7+ cell distribution in the 
superior colliculus of wildtype (b) and Pax7+/- mutant mice (c) at P5 showing reduced Pax7+ cells in the superficial strata of 
Pax7+/- mice. The cone at position 1 represents positive control for relative calibration. (d-e) Mean (+/-SEM) Pax7+ cellular dis-
tribution across rostrocaudal (d) and dorsoventral (e) axes. (f-g) Mean (+/-SEM) Pax7 protein levels across rostrocaudal (f) and 
dorsoventral (g) axes (n = 4 each).
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Pax3 expression profiles in the embryonic superior colliculus of Pax7 mutant and wildtype miceFigure 3
Pax3 expression profiles in the embryonic superior colliculus of Pax7 mutant and wildtype mice. Comparative 
Pax3 embryonic expression profiles in wildtype (a,b,c,e,g,i,k) and Pax7 mutant mice (d,f,h,j,l). Note the decreased intensity of 
Pax3 in the rostral region (a) relative to the caudal region (b) of the ventricular/subventricular zones at E12.5, and lack of 
immunoreactivity within the intermediate zone. At E15.5, Pax3+ cells are present in the hindbrain in wildtype mice (c, e [inset 
from c]) but are spatially expanded in Pax7 mutant mice (d,f [inset from d]). (Arrows denote spatial extent of expression). At 
the rostral mesencephalon at this timepoint there are increased numbers of Pax3+ cells in Pax7-/- mice relative to wildtype (g-h) 
together with expanded expression at the ventral ventricular surface (j), whereas Pax3 immunoreactivity was only detected in 
the dorsal ventricular region in wildtype mice (i). Consequently, at E18.5, whilst Pax3+ cells can be clearly detected in the ven-
tricular zone of wildtype mice (k) they are no longer present in Pax7-/- mice (l). Abbrev. IZ, intermediate zone; VZ/SVZ, ven-
tricular zone/subventricular zone. Scale bar: a-b, i-l 100 μm; c-d 500 μm; e-h 200 μm.
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afferent projection to the superficial superior colliculus
[15].
When we compared βIII-tubulin expression in the embry-
onic superior colliculus of wildtype mice to that of Pax7
mutant mice we could not discern any differences in
expression profiles (Fig 4a–b) (n = 2–3 at all embryonic
stages).
Similar results were obtained at E12.5 for α-internexin
(Fig 4c–d; n = 3), and doublecortin (Fig 4e–f; n = 3), early
markers of postmitotic [16] and migrating and differenti-
Comparative neuronal differentiation in the developing superior colliculus of Pax7 mutant and wildtype mice at E12.5Figure 4
Comparative neuronal differentiation in the developing superior colliculus of Pax7 mutant and wildtype mice 
at E12.5. Neuronal differentiation in the developing mouse tectum/superior colliculus of wildtype (a,c,e) and Pax7-/- mice 
(b,d,f) at E12.5, as indicated by βIII-tubulin (a-b),α-internexin (c-d) and doublecortin (e-f) immunostaining. Comparison shows 
similar neuronal differentiation, with increased spatial expression rostrally relative to caudally, with the rostral region slightly 
variable at different positions across the mediolateral axis, and neuronal differentiation mid-caudally restricted to the interme-
diate zone at the pial surface. Compare to the complementary expression of Pax3 at E12.5 (g). Scale bar: 200 μm.
BMC Developmental Biology 2008, 8:62 http://www.biomedcentral.com/1471-213X/8/62
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ating [17,18] neurons, respectively. Results confirm that
in mutant mice (n = 3 each) at E12.5, neuronal differenti-
ation occurs normally within the intermediate zone close
to the pial surface in a rostralhigh to mid-caudallow manner.
During all embryonic stages investigated, we could not
detect any difference in the cellular distribution of NeuN+
within the superior colliculus of Pax7 mutant mice rela-
tive to that of wildtype mice (n = 2–3). The tectum of
wildtype mice at E12.5 contains a small number of post-
mitotic, NeuN+ cells within the intermediate zone, distrib-
uted in a rostralhigh to caudallow manner (Fig 5a–b). At all
other embryonic stages examined, NeuN+ cells are distrib-
uted throughout the superior colliculus from ventral to
pial surfaces (Fig 5c–d).
By contrast, at P5, the most superficial region of the supe-
rior colliculus of Pax7 mutant mice is almost completely
devoid of NeuN+ cells (Fig 5f) indicating dorsal neuronal
loss at this important developmental time point. NeuN+
cells can be detected throughout the superior colliculus
and are in close proximity to the pial surface in wildtype
mice (Fig 5e) (n = 3–6). Interestingly, within the adult
mesencephalon (P18.5) NeuN, like Pax7, shows similar
expression in both mutant mice and wildtype mice (n =
2–5).
Alterations to superior collicular polarity in Pax7 mutant 
mice
Loss of Pax7+ cells and neurons in the dorsal superior col-
liculus at P5 (Fig 1g–h; Fig 2a–e; Fig 5e–f), when retinal
ganglion cell axonal innervation and arborisation is
occurring [15], would be expected to impact on superior
collicular polarity and retinotopic mapping. We therefore
assessed ephrin-A2 expression in Pax7 mutant mice rela-
tive to expression in wildtype littermates. Consistent with
the altered Pax7 and NeuN profile, at P5 ephrin-A2+ cells
are missing in the most superficial region (Fig 5h,j), in
contrast to wildtype expression displaying immunoreac-
tivity close to the pial surface (Fig 5g,i), providing further
evidence of neuronal loss and changes to polarity.
Neuronal loss is not due to astrocytic cell-fate switching or 
transdifferentiation
To assess the likelihood of astrocytic cell-fate switching or
transdifferentiation, we analysed GFAP expression in
postnatal stages as the majority of gliogenesis occurs
within the first postnatal week [19]. We could not detect
co-expression of Pax7 and GFAP at P5 or P18.5 in either
wildtype or Pax7 mutant mice, consistent with previous
results determined in the chick tectum [20]. GFAP+ proc-
esses can be seen extending from cells located at the pial
surface, however the dorsal regions of the superior collic-
ulus in Pax7 mutant mice are similar to wildtype mice and
are not populated by GFAP+ cells within the region of per-
turbation at P5 or P18.5 (Fig 6a–d), indicating that cell
fate switching or transdifferentiation to the astrocytic lin-
eage is not responsible for the reduced dorsal expression
of Pax7, NeuN and ephrin-A2 at this stage (n = 3–4).
Neuronal loss may be attributable to cellular regression
To evaluate whether neuronal loss was due to apoptosis,
we investigated activated caspase 3 expression from E15.5
to P5, however we did not detect either co-expression with
Pax7 at any stage, or increased numbers of cells in mutant
mice relative to wildtype (data not shown). This marker,
however, proved difficult to analyse as elevated and wide-
spread immunoreactivity detected at the earlier embry-
onic stages tested may be due to the emerging role of
caspase 3 in neuronal differentiation [21]. We therefore
utilised Hoechst as an indicator of pyknotic nuclei, and
assessed co-expression with activated caspase 3 as confir-
mation of the apoptotic status of the cells, but only a few
apoptotic cells were detected at any given time point. The
identification of apoptotic cells would, however, require
knowledge of the exact timeframe in which the neurons
were lost, due to rapid neuronal degeneration noted pre-
viously [22].
Mesencephalic boundary formation
To explore the effects of perturbed Pax7 expression on for-
mation of superior collicular boundaries, ie between the
diencephalon and mesencephalon and between the supe-
rior colliculus (dorsal) and tegmentum (ventral mesen-
cephalon), we assessed Pax6 expression at the rostral and
ventral boundaries of the superior colliculus [4,9,23]. At
E12.5, there are a few weakly-stained Pax6+ cells superior
to the interpeduncular fossa. At E15.5 in wildtype mice,
Pax6+ cells can be detected dorsally in the pretectum (Fig
6e,f) sometimes spreading to the rostral margin of the
ventricular zone. Pax6 immunoreactivity could not be
detected within the pretectum at E18.5 in either wildtype
or mutant mice. We could not detect any abnormality in
the expression domain of Pax6 in Pax7 mutant mice at
these midgestational stages (n = 3).
To investigate alterations to mesencephalic/meten-
cephalic boundary formation, we assessed the expression
of the marker En-1 [24] from E15.5 to P18.5. En-1+ cells
can be detected at the midbrain/hindbrain boundary,
from the interpeduncular fossa to the rhombencephalic
isthmus (Fig 6g,h) and expression wanes as development
proceeds until P18.5, when En-1 expression in the mid-
brain is usually restricted to a cluster of cells superior to
the interpeduncular fossa. Throughout all stages exam-
ined, we could not detect any difference between wildtype
and mutant mice (n = 2–3).
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Comparative NeuN and ephrin-A2 expression profiles in the superior colliculus of Pax7 mutant and wildtype miceFigure 5
Comparative NeuN and ephrin-A2 expression profiles in the superior colliculus of Pax7 mutant and wildtype 
mice. NeuN expression demonstrates increased rostral expression (a) compared to caudal expression (b) at E12.5, indicating 
that rostral maturation precedes that of the caudal region. Figures (c) and (d) illustrate a full complement of NeuN+ cells dor-
sally at E15.5 and E18.5, respectively, in Pax7 mutant mice consistent with wildtype expression (data not shown). Comparison 
at P5 between wildtype (e) and Pax7 mutant mice (f) indicates a loss of neurons dorsally. Likewise, analysis of ephrin-A2 expres-
sion shows perturbation between wildtype (g,i) and Pax7 mutant mice (h,j) in the dorsalmost region. Scale bar: a-c,e-f 100 μm; 
d,i-j 200 μm; g-h 500 μm.
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Comparable astrocytic profile in the dorsal superior colliculus of wildtype and Pax7 mutant miceFigure 6
Comparable astrocytic profile in the dorsal superior colliculus of wildtype and Pax7 mutant mice. Immunofluo-
rescent detection of GFAP indicates a normal astrocytic profile at P5 (a-b) and P18.5 (c-d) for wildtype (a,c) and Pax7 mutant 
mice (b,d). (a') Positive control indicating GFAP expression in astrocytes of the myelencephalon. GFAP+ processes extend from 
cells located at the pial surface, however the dorsal half of the superior colliculus in Pax7-/- mice, like that of wildtype, is not 
populated by GFAP+ cells. Therefore, cell fate switching and/or transdifferentiation towards the astrocytic lineage does not 
account for the reduction in Pax7+ cells dorsally. Immunohistochemical detection of Pax6 (e, f, [inset from e]) and Engrailed 
(En-1) (g, h [inset from g]) was utilised to examine mesencephalic boundary formation, which appear morphologically unaf-
fected in Pax7 mutant mice. Abbrev. Cc, cerebral cortex; Ipf, interpeduncular fossa;Mes, mesencephalon; Pt, pretectum; Ri, 
rhombencephalic isthmus. Scale bar: a-d,f,h 100 μm; e,g 500 μm.
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Discussion
In order to understand the role of Pax7 in superior collic-
ular development we investigated the superior colliculus
of Pax7 mutant mice relative to wildtype at a variety of
developmental stages. Whilst both Pax3 and Pax7 are
known to define the early tectum subsequent to mesen-
cephalic determination, and the ability to form ectopic
tectum subsequent to misexpression within the dien-
cephalon and ventral mesencephalon testifies to their crit-
ical nature in specification of tectal identity [5], individual
roles during further development have remained elusive.
Here we show that loss of Pax7 dramatically alters Pax3
expression domains and disturbs the neuronal profile in
the dorsal layers of the developing superior colliculus.
Pax7 and Pax3 have separate roles during neuronal 
differentiation in the superior colliculus
Since Pax7 and Pax3 have similar expression domains in
the developing superior colliculus at mid-gestation [9], we
undertook a thorough, comparative analysis of their
expression patterns in wildtype and mutant mice. It was
anticipated that this analysis would highlight any changes
caused by loss of Pax7 and shed light on their individual
roles during superior collicular development.
Results indicate that as the superior colliculus emerges
and the dorsal laminae are formed by cellular migration
and differentiation, Pax7 expression becomes progres-
sively more refined towards the upper, developing strata
whereas Pax3 expression becomes increasingly restricted
towards the proliferative region (Fig 7). At E12.5, Pax7-
and Pax3-expressing cells overlap in the ventricular and
subventricular zones, but not in the emerging, differenti-
ating intermediate zone.
At E15.5 tectal Pax7 expression within the ventricular
zone decreases, and is no longer evident at E18.5, with
expression persisting within the upper developing pri-
mary layers (strata profundum, intermedium and superfi-
ciale). However, Pax3 expression becomes restricted to the
ventricular zone, with a few scattered cells within the
intermediate region at E15.5 decreasing at E18.5. Postna-
tally, expression of Pax7 is detected throughout the supe-
rior colliculus, numerically declining with maturation yet
persisting at all developmental stages examined, whilst
Pax3 expression is extinguished.
The divergent Pax3/Pax7 expression profiles, as demon-
strated in this paper, suggest a dichotomy of function with
respect to neuronal differentiation. The Pax7 expression
profile, without co-expression of Pax3, appears spatially
associated with neuronal differentiation and maturation
of the superior colliculus, whilst Pax3 expression appears
to be negatively associated with these characteristics. A
role for Pax3 in maintaining the undifferentiated pheno-
type has been demonstrated previously, both in vitro and
in vivo for neuronal cells [25,26], for Schwann cells [27]
and for melanoblasts [28,29]. Conversely, transfection of
Pax7 into P19 mouse embryonal cells in vitro directs these
cells along a neuronal pathway [30]. This dichotomy may,
therefore, represent an important functional divergence
between paralogues which may have implications for
future stem cell therapies designed to treat midbrain dis-
orders.
To investigate this further, we performed a comparative
assessment of βIII-tubulin, α-internexin, doublecortin and
NeuN expression at E12.5, just prior to the normal birth-
date of the superficially located neurons. At this time-
point, the intermediate zone appears as an expanded
region rostrally (which varies slightly at different posi-
tions across the mediolateral axis) diminishing to a thin
region at the pial surface mid-caudally, indicating a rostral
to caudal maturity, and is characterised by the expression
of Pax7, βIII-tubulin (somatic staining), α-internexin, dou-
blecortin and NeuN, and morphologically by increased
internuclear distances. By contrast, Pax3 expression can-
not be detected within the intermediate zone. We could
not discern any evidence of precocious neuronogenesis at
this time, a function previously demonstrated for Pax6
within the eye of Sey mutant mice [31]. However, a more
thorough investigation at closer temporal increments
from E13 would be required to thoroughly preclude this
possibility, as precocious or more rapid neuronogenesis
may occur between the time frames investigated in this
study. Furthermore, the perturbation to Pax3 expression
within the ventricular zone at the later embryonic stages
investigated, suggests that the early processes of specifica-
tion and/or migration may be accelerated somewhat with
insufficient Pax7 levels. The unaltered proliferation/spec-
ification of tectal cells does not preclude a role for Pax7 in
these processes per se, but may indicate compensation via
Pax3.
The observed perturbations in Pax3 expression in Pax7
mutant mice may indicate that Pax7 acts to limit the
expression domain of Pax3. This is supported by the ros-
tral, ventral and caudal expansion of Pax3+ cells in the
presence of reduced or absent Pax7 expression. These
regions of expanded expression occur where Pax7 expres-
sion would normally be encountered, and suggests that
Pax7 acts to dorsalise (or at least positionally constrain)
Pax3 expression. A cell autonomous relationship between
Pax7 and Pax3 has been determined whereby misexpres-
sion of one paralogue represses expression of the other,
and a balancing mechanism may exist to produce correct
total expression levels [5]. The exact mechanism behind
this relationship is ambiguous, however it may be signifi-
cant that the expression of Pax7 precedes that of Pax3
within the headfold and primitive fold ectoderm in the
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developing chick [2]. Moreover, it is clear that this rela-
tionship is also dosage-sensitive, as perturbations occur in
the haploinsufficient state.
Role for Pax7 in timing of neuronal specification
Expression analysis and cellular quantification have dem-
onstrated that Pax7 haploinsufficiency does not alter the
Schematic illustration of divergent Pax7 and Pax3 expression profiles in the embryonic mouse superior colliculusFigure 7
Schematic illustration of divergent Pax7 and Pax3 expression profiles in the embryonic mouse superior collicu-
lus. Divergent Pax7 (a,c,e) and Pax3 (b,d,f) embryonic expression profiles in wildtype mice at E12.5 (a-b), E15.5 (c-d) and E18.5 
(e-f). The lighter pattern for Pax7 and Pax3 indicates low levels of expression compared to other regions (such as developing 
upper strata or ventricular zone, respectively) showing darker staining. Abbrev. Cc, cerebral cortex; Ce, cerebellum; CeP, cere-
bellar primordium; ChP, choroid plexus; Di, diencephalon; My, myelencephalon; Po, pons; Pr, prosencephalon; Pt, pretectum; St, 
subthalamus; SuC, superior colliculus; T (Me), tectum (mesencephalon); 3v, 3rd ventricle; 4v, 4th ventricle. Illustrations are not to 
scale.
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initial proliferation steps in Pax7+ cells during mid embry-
onic stages. The only notable disparity to Pax7 expression
occurs at P5, where a subpopulation of Pax7+ cells, situ-
ated in the dorsal half of the superior colliculus, is no
longer detectable, presenting with an obvious margin
lacking Pax7+ cells superficially. Sagittal and coronal sec-
tions have identified that this perturbation occurs across
the dorsal surface of the entire rostrocaudal axis and most
of the mediolateral axis.
To understand the significance of this anomaly we
reviewed previous studies, which indicate that the major-
ity of superior collicular neurons are born throughout the
period E11 to E13 [14,19] and distinct temporal and spa-
tial migration patterns culminate in dictation of the cor-
rect cytoarchitecture of the developing superior colliculus
(Fig 8). Cells generated at E11 initially migrate to popu-
late the superior colliculus, and are subsequently divided
dorsoventrally by cells generated at E13 [14]. The cells
that eventually reside within the most superficial region of
the superior colliculus undergo their final postmitotic
division at E13 while in the ventricular/subventricular
zones, and migrate to subdivide their predecessors in the
intermediate zone at E15. Thereafter, a subpopulation
assume their final position superficially at E17 [14] which
coincides with retinal ganglion cell innervation of both
superficial and intermediate zones [15,32]. The stratum
superficiale thus contains cells generated at both E11 and
E13, with the latter cells being more superficially placed.
In contrast, the ventral regions of the superior colliculus,
associated with auditory and motor responses, undergo
earlier development than the superficial regions and are
thus populated by earlier-born neurons [14,33,34]. This
temporal specification of cells is similarly observed in the
chick tectum, where two populations of cells are gener-
ated, each with distinct laminar fates, with later born neu-
rons expressing Pax7 fated to reside in the more dorsal
laminae [35]. It is therefore evident that the timely migra-
tion of cells from the ventricular zone contributes to the
correct placement of cells within the superficial laminae,
and this temporal-based specification of neurons ensures
that placement of cells within laminae coincides with
their maturation and initiation of circuitry.
Overall, our results tend to suggest that Pax7 may partially
contribute to the correct timing of neuronogenesis by reg-
ulating migration of Pax3+ cells from the ventricular zone
into the mid-collicular region in a timely and orderly fash-
ion, a characteristic that is lost in Pax7-/- mice between
E15.5 and E18.5, at the time when wildtype cells destined
to reside in the more superficial strata are migrating and
assuming their final destination.
A putative anti-apoptotic role for Pax7 in postnatal 
superior collicular development
As earlier quantification did not detect any numerical
changes in the Pax7 cellular profile in Pax7+/- mice, it
became apparent that these cells had either altered their
differentiation profile or had regressed within the first
postnatal week. We assessed GFAP expression postnatally
and as there was no change in the cellular distribution of
GFAP+ cells in Pax7 mutant mice we excluded cell fate
switching or transdifferentiation to the astrocytic lineage
as a causative factor for the reduced number of Pax7+ cells
dorsally. We were, however, unable to detect increased
apoptosis within the superior colliculus using activated
caspase 3, cresyl violet or Hoechst staining. A more
detailed examination commencing from birth would be
required to determine the exact time interval when pertur-
bation occurs in order to conclusively demonstrate apop-
totic mechanisms. Apoptotic labelling methods such as
TUNEL or caspase 3, concomitant with Pax7 immunola-
belling, would be required to address this issue, however
rapid neuronal degeneration coupled with a progressive
rostrocaudal maturation to the tissue which is likely to
result in a punctuated apoptotic phenomenon, will likely
impede the quantitative nature of the analysis required to
differentiate between normal (wildtype) and increased
(mutant) apoptosis. However, the loss of neurons evi-
A diagrammatic representation of the primary layers of the developing supe ior colliculusFigure 8
A diagrammatic representation of the primary layers 
of the developing superior colliculus. The laminae of the 
developing superior colliculus contain two populations of 
cells that populate the upper (SS), mid (SI) and lower (SP) 
regions. At E15, cells generated at E11 populate the SS and 
SP, whereas cells generated at E13 intersect these regions to 
populate the SI, with a subsequent migration of a subpopula-
tion upwards to the SS by E17. Thus, the SS consists of two 
different populations of cells, with the most recently gener-
ated cells residing in the more superficial regions. Adapted 
from [14]. Abbrev. SS, strata superficiale; SI, intermedium; SP, 
profundum. "Cells Migrated" column relates to the develop-
mental timepoint when the cells have migrated to their final 
destination.
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denced in Pax7 mutant mice indicates a loss of cells, rather
than simply extinction of Pax7 expression.
Relating phenotype to the specification of cells during
superior collicular development [14] suggests that the sec-
ond population of neurons, generated at E13, may be less
capable of long-term survival than their earlier-produced
counterparts, and as such are sensitive to gene dosage (Fig
9). Whilst the differential placement of late-born neurons
identified in previous studies [14,35] coincides spatially
with the perturbed neuronal profile of Pax7 mutant mice
further experimentation is required to distinguish a link
between the generation of subpopulations of cells and
their relationship with Pax7 and postnatal cytoarchitec-
ture. Furthermore, differential sensitivity to neuron death
has been suggested for different functional populations of
neurons within the superior colliculus [36]. Anti-apop-
totic roles for Pax genes are well-documented to-date [37-
41] and, importantly, the ciliary neurotrophic factor
receptor has recently been demonstrated as a downstream
target of Pax7 within the mouse embryo [42].
Apparent neuronal recovery at P18.5
We have demonstrated altered Pax7+ and neuronal pro-
files in Pax7 mutant mice at P5, however at P18.5 we can
no longer detect these variations between Pax7 mutant
and wildtype mice. Whilst it is feasible that the similar
number of Pax7+ cells in Pax7+/- mice relative to wildtype
at P18.5 occurs because Pax7+ cells in the adult do not
normally include the subpopulation of cells which are
missing at P5 in Pax7 mutant mice, the apparent recovery
of the neuronal profile by P18.5 has proven enigmatic. We
have drawn from established studies of CNS and superior
collicular development to address this issue.
It is clear that early postnatal stages of superior collicular
development are tumultuous. The colliculus becomes
invaded by retinal afferents just prior to birth and this
continues within the first postnatal week, with formation
of collaterals giving rise to axonal arborisation and com-
mencement of synaptogenesis [15,43,44]. During this
process, a dramatic transformation occurs in which
almost half of all fibre bundles are removed from the
upper half of the stratum superficiale (the region including
the perturbation where Pax7+ cells are essentially absent)
[15,44]. This process coincides with naturally occurring
neuron death in the superior colliculus [36,45], indicating
neuronal formation in excess of adult requirements.
Excessive neuron formation is a recurrent theme in CNS
development [22,46,47]. Therefore it is likely that exces-
sive neuron formation masks the loss of the more suscep-
tible, Pax7-deficient neurons, with sufficient cells
remaining to satisfy functional requirements. Subse-
quently, displacement of cells due to fibre invasion and
A diagram detailing differential placement of separately generated populations of Pax7+ cells at P5Figure 9
A diagram detailing differential placement of separately generated populations of Pax7+ cells at P5. A diagram 
of Pax7+ cells in the superior colliculus of wildtype (a) and Pax7 mutant (b) mice at P5. Cells generated at E11 (red) and E13 
(purple) show overlapping (medial) and unique (ventral [E11]/dorsal [E13]) expression patterns (a). We propose that cells gen-
erated at E13 show reduced capacity for long term maintenance in Pax7 mutant mice (b), generating a phenotype whereby a 
superficial region is absent of Pax7+ cells, and the region immediately ventral to this exhibits a reduction in the number of Pax7+ 
cells (refer Fig 2e). Abbrev. CC, cerebral cortex; IC, inferior colliculus.
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the ensuring maturation of the tissue could possibly
account for the apparent phenotypic equivalence of
NeuN+ cells noted at P18.5. It should be noted that func-
tional studies have not been performed on Pax7 mutant
mice to-date to assess visual acuity.
Further studies
A possible cause for the loss of superficial neurons in early
postnatal stages could be altered circuitry. Neurons of the
superficial superior colliculus communicate with the
deeper collicular regions through superficial neuronal
axons [48,49], or via dendrites from neurons of the deep
layers [50] which in turn contain a variety of efferent pro-
jections from regions such as the cortex, retina, zona
incerta (region surrounding subthalamus) [32,51-53] and
indirectly from the subthalamus via the substantia nigra
pars reticulata or enteropeduncular nucleus [54-56]. Tak-
ing this into consideration, an interesting finding from
this research is the persistent Pax7+/Pax3- expression pro-
file of the subthalamus throughout all timepoints exam-
ined. Providing Pax3 is not expressed in this region at an
earlier developmental stage than examined in this study,
the subthalamus may represent a novel opportunity to
further dissect the functional repertoire of Pax7 from that
of Pax3. Additional work would therefore be required to
characterize the subthalamus of Pax7 mutant mice to
address this issue, as this important brain region is a target
of deep brain stimulation to treat disorders such as Par-
kinson's Disease and epilepsy [56,57].
Further studies on the role of Pax7 in superior collicular
development would benefit from investigation into the
axonal projection and circuity of Pax7+ cells, which may
be elaborated by the generation of Pax7/tau-labelled X
Pax7 mutant mice. Cell lineage tracing experiments in
Pax7 mutant mice would be required to trace the progres-
sion of cells generated at E11 and E13 to conclusively
resolve the questions related to the early postnatal pertur-
bation and the apparent neuronal recovery in the adult.
Moreover, functional studies assessing the ability of Pax7
mutant mice to evoke a co-ordinated response to stimuli
will be required to assess the integrity of the mature supe-
rior colliculus.
Conclusion
In summary Pax7, while not required for neuronogenesis
or neuronal differentiation at early stages of superior col-
licular development, is absolutely requisite in a dosage-
dependent manner for long term maintenance of a sub-
population of dorsal mesencephalic neurons. This charac-
teristic may well impart prophylactic properties to stem
cells utilised in future replacement therapies to enhance
treatment of neurodegenerative diseases of the midbrain.
Furthermore, comparative expression analyses indicate a
functionally divergent role for Pax7 and Pax3 during neu-
ronal differentiation within the superior colliculus.
Methods
Mouse tissue
The generation and genotyping of Pax7 mutant mice has
been described previously [10]. Principles of laboratory
animal care (NIH publication No. 86-23, revised 1985)
were followed, and animal experimental procedures con-
formed to National Health and Medical Research Council
of Australia guidelines, with approval by the Animal Eth-
ics Committee of Edith Cowan University. The produc-
tion of transgenic animals at the Max Planck Institute for
Biophysical Chemistry was performed with the approval
of LAVES (Landesamt für Verbraucherschutz und Lebens-
mittelsicherheit) in Oldenburg.
Whole embryos (E12.5) or embryonic brains (>E15.5)
from mutant and wildtype littermates were isolated and
postfixed in 4% paraformaldehyde. Postnatal mice were
deeply anaesthetised with Avertin and intracardially per-
fused with fixative. Brains were isolated and postfixed
with 4% paraformaldehyde. Tissue was cryoprotected in
20% or 30% sucrose/PBS prior to sectioning. Embryos at
E12.5 were sectioned whole. For all other stages, brain
hemispheres were sectioned in the sagittal (left) or coro-
nal (right) planes at 10–20 μm, and slides were stored at -
80°C until required. A minimum of three animals per
group (+/+; +/-; -/-) per timepoint were analysed (with the
exception of Pax7-/- animals at E18.5, where n = 2).
Immunohistochemistry
Whole embryo tissue from E12.5 mice was subjected to
antigen retrieval by microwave heating in sodium citrate
buffer pH6.0 prior to processing. All tissue sections were
treated with 0.2% Triton-X100/PBS (10 min), 1.5%
H2O2/PBS (2–3 × 10 min), blocked with 10% fetal calf
serum/PBS (30 min) and incubated overnight at 4°C with
primary antibodies; Pax7 (1:20 or 1:10 (E12.5), mouse,
monoclonal, DSHB, Iowa City, IA, USA); Pax3 (1:100 or
1:50 (E12.5), mouse, monoclonal, DSHB, Iowa City, IA,
USA); Pax6 (1:100, mouse, monoclonal, DSHB, Iowa
City, IA, USA); En-1 (1:50, mouse, monoclonal, DSHB,
Iowa City, IA, USA); ephrin-A2 (1:500, rabbit, polyclonal,
Santa Cruz Biotechnology, Santa Cruz, CA, USA); NeuN
(1:100, mouse, monoclonal, Chemicon/Millipore, Biller-
ica, MA, USA). Sections were then incubated with bioti-
nylated anti-mouse/anti-rabbit IgG (1:3, Dako, Sydney,
NSW, Australia) followed by streptavidin/HRP complex
(1:3, Dako, Sydney, NSW, Australia) (20 mins each at
room temperature). Visualization with diaminobenzidine
(3% in substrate buffer, Dako, Sydney, NSW, Australia)
preceeded processing through an ethanol series/xylene,
and mounting in DePex. Control slides without primary
antibodies were immunonegative.
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Immunohistochemical quantification and analysis
Images were captured with a Leica DC300 camera
attached to an Olympus BX41 microscope and analysed
using Optimas 6.5 Digital Image Analysis software (Media
Cybernetics, Bethesda, MD, USA). For cellular quantifica-
tion at E15.5 and P18.5 images were captured within
Optimas (100× magnification) and Pax7+ cells were
marked and counted. For optical density and cell distribu-
tion measurements at P5, the microscope was equili-
brated prior to analysis, and microscope and image
software settings were standardised. Measurements of
Pax7 immunostaining were obtained on a frame-by-frame
basis (400× magnification), and encompassed the entire
Pax7+ portion of the superior colliculus, producing a serial
reconstruction of the region (Coggeshall and Lekan
1996). Each individual cell measurement was topograph-
ically replotted within Excel and values were normalised
against immunonegative adjacent tissue. Results were
subsequently analysed producing maps of mean cellular
distribution, or graphed as either mean cellular protein
level or mean cell number at each axis point. Standard
errors are shown.
Immunofluorescence
Tissue sections were blocked with 3% normal goat serum
(NGS)/0.2% Triton-X100/TBS (TX-TBS) for one hour at
room temperature and incubated overnight at 4°C with
primary antibody diluted in 1% NGS/TX-TBS. Primary
antibodies included Pax7 (1:10); Pax3 (1:50); activated-
Caspase 3 (1:100, rabbit, polyclonal, Promega, Sydney,
NSW, Australia); alpha-internexin (1:150, rabbit, polyclo-
nal, Chemicon/Millipore, Billerica, MA, USA); βIII tubu-
lin (TuJ1)(1:500, rabbit, polyclonal, Abcam, Cambridge,
MA, USA); Doublecortin (1:500, rabbit, polyclonal,
Abcam, Cambridge, MA, USA); GFAP (1:1000, rabbit,
polyclonal, Chemicon/Millipore, Billerica, MA, USA);
Ki67 (1:150, rabbit, polyclonal, Abcam, Cambridge, MA,
USA). Primary antibodies were visualised with conjugated
anti-rabbit IgG-AlexaFluor488 (1:500; Molecular Probes-
Invitrogen, Melbourne, VIC, Australia), or biotinylated
goat anti-mouse IgG (1:500; Abcam, Cambridge, MA,
USA), incubated overnight followed by streptavidin-
AlexaFluor546 (1:500; Molecular Probes-Invitrogen, Mel-
bourne, VIC, Australia), incubated for 2 hours at room
temperature. Slides were counterstained with Hoechst (1/
5000; Sigma Aldrich, Sydney NSW, Australia) and
mounted in Fluorsave (Calbiochem, La Jolla CA, USA).
Controls with primary antibodies omitted were immu-
nonegative. Fluorescent micrographs and the confocal z-
stack image (see Additional file 1) were obtained using
Confocal Assistant software (Version 4.02) and the Biorad
MRC 1000/1024 Confocal Microscope or Olympus BX41
microscope equipped with an Olympus DP71 camera.
Statistical analysis (Table 1)
To assess variation between wildtype and mutant mice at
E15.5, P5 and P18.5, we compared the number of Pax7+
cells in wildtype mice with those in Pax7+/- mice using
paired t test (two-tailed). For determination of graded
expression at P5, mean values at three points across each
axis (rostral, mid and caudal, or ventral, mid and dorsal)
were calculated by averaging cell numbers in two frames
at each axis position. Graded expression across each axis
was assessed by analysis of significant variation between
axis points using the paired t test (two-tailed): rostral vs
mid (R-M), mid vs caudal (M-C), rostral vs caudal (R-C)
or ventral vs mid (V-M), mid vs dorsal (M-D), ventral vs
dorsal (V-D). Corresponding significance values are
reported in Table 1. All statistical analyses were conducted
utilising SPSS Version 13.0 Statistical Software, with a
95% confidence interval.
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